<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CDD64036-C7C4-4924-8321-6076FB363042"><gtr:id>CDD64036-C7C4-4924-8321-6076FB363042</gtr:id><gtr:name>University of Sunderland</gtr:name><gtr:address><gtr:line1>Floor 2</gtr:line1><gtr:line2>Edinburgh Building</gtr:line2><gtr:line3>Chester Road</gtr:line3><gtr:line4>Sunderland</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>SR1   3SD</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA"><gtr:id>7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA</gtr:id><gtr:name>University of Otago</gtr:name><gtr:address><gtr:line1>PO Box 56</gtr:line1><gtr:line4>Dunedin</gtr:line4><gtr:line5>9016</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:department>Biological and Biomedical Sciences</gtr:department><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46B41008-0EB4-4E28-BBFB-E98366999EC5"><gtr:id>46B41008-0EB4-4E28-BBFB-E98366999EC5</gtr:id><gtr:name>Durham University</gtr:name><gtr:address><gtr:line1>Old Shire Hall</gtr:line1><gtr:line2>Old Elvet</gtr:line2><gtr:line4>Durham</gtr:line4><gtr:line5>County Durham</gtr:line5><gtr:postCode>DH1 3HP</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C60CE47-6ED7-4C38-BF0D-BEE689253646"><gtr:id>9C60CE47-6ED7-4C38-BF0D-BEE689253646</gtr:id><gtr:name>Servier Laboratories</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CDD64036-C7C4-4924-8321-6076FB363042"><gtr:id>CDD64036-C7C4-4924-8321-6076FB363042</gtr:id><gtr:name>University of Sunderland</gtr:name><gtr:address><gtr:line1>Floor 2</gtr:line1><gtr:line2>Edinburgh Building</gtr:line2><gtr:line3>Chester Road</gtr:line3><gtr:line4>Sunderland</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>SR1   3SD</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA"><gtr:id>7A2E29F2-7BB5-49F8-A719-BCDDF0C000FA</gtr:id><gtr:name>University of Otago</gtr:name><gtr:address><gtr:line1>PO Box 56</gtr:line1><gtr:line4>Dunedin</gtr:line4><gtr:line5>9016</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>New Zealand</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E79EC2E5-7E77-4364-8001-2809C151CC04"><gtr:id>E79EC2E5-7E77-4364-8001-2809C151CC04</gtr:id><gtr:firstName>C</gtr:firstName><gtr:surname>Thompson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D0C6CED-904D-4EA0-BE59-D6C49B98C3AC"><gtr:id>6D0C6CED-904D-4EA0-BE59-D6C49B98C3AC</gtr:id><gtr:firstName>Antony</gtr:firstName><gtr:otherNames>Ryszard</gtr:otherNames><gtr:surname>Slabas</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401395"><gtr:id>967DEAE9-F32E-4C5E-A83A-DD5F07263826</gtr:id><gtr:title>Biochemical and proteomic approaches to investigating activity-dependent regulation of stargazin in mammalian neurones</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401395</gtr:grantReference><gtr:abstractText>Nerve cells (neurones) communicate by releasing chemical messages ?neurotransmitters? that transmit the message to specific message-receptive proteins, ?receptors? in the message-receiving neurone. These events occur in specialized structures, synapses, where the release site and suitable ?receptor? are juxtaposed. It is imperative for compentent neuronal communication that the receptor be trafficked and targeted to the appropriate synapse. Furthermore, the number and stability of the receptors placed in the receptive zone needs to have some degree of ?plasticity? so that it is capable of accommodating different rates of delivery. If messages are transmitted at high frequency ?these might be important messages that need a special response and some mechanisms for recalling the importance of this particular message. In the case of excitatory neurotransmission, glutamate is the neurotransmitter and for moment to moment communication, the ?AMPA receptor? is the responsive element. How do the AMPA receptors get to the appropriate synapse and how are the number and stability of the AMPA receptors altered to interpret and respond appropriately to important messages? These questions form the basis of this project proposal. A family of proteins, the TARPs (Transmembrane AMPAR Regulatory Proteins) have recently been identified and shown to be important components of the protein machines that shuttle AMPARs from their site of assembly to their final destination in the excitatory synapse. But they don?t operate alone, many other proteins known and unknown are also required but what are they? When are they required? And what do they contribute to this whole complex process? This is what we hope to discover here. 
To illustrate how important TARPs are consider the stargazer mouse, it fails to make one particular TARP family member,the TARPgamma2 variety. As a consequence the mouse develops absence epilepsy, motor co-ordination, balance and posture difficulties (ataxia) and inner ear problems. Furthermore, the proteins that they help to traffic and target are important in processes such as learning and memory ?dysfunctional TARPs may result in cognitive impairment. Our aim is to identify proteins that assist and regulate TARPs, establish how they know when to perform their tasks and how efficiently and hard they need to work.
This information will be transmitted to the public in oral presentations and posters at Durham?s Brain Awareness Week which I organise, Neuroscience-North East - a conference organized for early-career neuroscientists in which I?m also involved and at the annual Durham Science Fair for local school children.</gtr:abstractText><gtr:technicalSummary>The excitatory, ionotropic, glutamate-gated AMPA receptors (AMPARs) undergo constitutive rapid cycling at the synapse. Activity-dependent modulation of the rate of delivery and/or removal of AMPARs to/from the synapse underpins synaptic plasticity events such as LTP/LTD and is considered central to cognitive function. Although a raft of AMPAR-interacting proteins has recently been identified, each having a specific, sometimes transient role to play, little is known about the repertoire of proteins involved, nor the molecular mechanisms responsible for the transport to and retention of AMPARs at the synapse. Novel approaches are required if we are to dissect-out specific multi-protein complexes and to identify and assign function to all the individual components. Transmembrane AMPAR Regulatory Proteins (TARPs), e.g. stargazin (TARPgamma2) play a role in AMPAR trafficking and synaptic targeting. TARPs are subject to neuronal activity-dependent post-translational modifications e.g., phosphorylation/glycosylation which appear to be cell compartment specific. How these post-translational modifications of TARPgamma2 arise, how they influence its function, its multi-protein complex formation and AMPAR signaling remain largely unknown. TARPs are expected to be pivotal to AMPAR-mediated brain development, neuronal communication and cognitive functions but might also be implicated in disorders e.g. epilepsy and Alzheimer?s disease and hence may have potential as novel targets for drug design.
Aims and objectives:
(1) We will immunoaffinity purify non-synaptic and synaptic TARP-complexes from mouse cerebellar neurones (TARPgamma2) and glia (TARPgamma4). Applying standard proteomics approaches including 1D-gel and 2D-gel separations followed by MALDI-MS and/or LC-MS-MS analysis we will identify the complement of respective TARP-interacting proteins and begin to construct their proteomic maps.
(2) AMPAR agonists dissociate TARPgamma2-AMPAR interactions. This probably occurs at glutamatergic synapses to either signal transfer of AMPAR from TARPs to the post-synaptic density or initiate AMPAR internalization, recycling or degradation. Procedures will be applied as in (1) to evaluate whether the repertoire of TARP-associated proteins is affected when TARPs are AMPAR-associated (+CNQX) versus AMPAR-dissociated (+glutamate).
(3) Using TARPgamma2-expressing cultured mouse cerebellar granule cells (mCGCs) pharmacologically manipulated to regulate neuronal activity and signalling we will investigate by immunoblotting, cell surface labeling, protein turnover assays etc., how the post-translational status, function and, by fluorescence confocal microscopy, cellular location of TARPgamma2 and associated-AMPARs is affected by neuronal activity. 
(4) We will virally infect TARPgamma2 -/- mCGCs with modified GFP-TARPgamma2 expression constructs and by a proteomics approach as in (1) and (2) determine how post-translational modifications and TARPgamma2 domains influence the assembly of TARPgamma2-multiprotein complexes and their function.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-01-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>271259</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Otago</gtr:collaboratingOrganisation><gtr:country>New Zealand</gtr:country><gtr:description>Professor George Lees</gtr:description><gtr:id>F3145E15-5592-4C12-A25B-41F169664FAA</gtr:id><gtr:impact>17986225 16914686 Plus multiple further peer-reviewed publications on other neuroscience topics</gtr:impact><gtr:outcomeId>03A6FDA76DC-1</gtr:outcomeId><gtr:partnerContribution>Expertise in slice electrophysiology</gtr:partnerContribution><gtr:piContribution>Molecular basis for AMPA receptor regululation mechanisms</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Servier Laboratories</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:description>Professor Mike Spedding</gtr:description><gtr:id>5290E2EF-0A5B-45B5-9B7F-64168674036B</gtr:id><gtr:impact>Future Publications Established funded PhD studentship</gtr:impact><gtr:outcomeId>212FCF103F8-1</gtr:outcomeId><gtr:partnerContribution>Access to novel Pharmacological tools</gtr:partnerContribution><gtr:piContribution>Immunological Tools and model systems</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Durham University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Pharmacy</gtr:department><gtr:description>Link between emotion and chronic pain</gtr:description><gtr:id>CEFEE9A3-7A22-4DB9-B86D-772B4A503387</gtr:id><gtr:impact>In development</gtr:impact><gtr:outcomeId>kznSEQA3CjN-1</gtr:outcomeId><gtr:partnerContribution>Extensive experience in a range of pain models</gtr:partnerContribution><gtr:piContribution>Pharmacological, behavioural and immunological tools</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sunderland</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Pharmacy, Health and Well-being</gtr:department><gtr:description>Dr Abdel Ennaceur</gtr:description><gtr:id>53F61615-D1C0-41B3-803B-23D8208BB89C</gtr:id><gtr:impact>Joint patent filed in October 2010

Tolerance, sensitization and dependence to diazepam in Balb/c mice exposed to a novel open space anxiety test.Ennaceur A, Michalikova S, van Rensburg R, Chazot PL.Behav Brain Res. 2010 May 1;209(1):154-64.PMID: 20117142

Anxiety responses in Balb/c, c57 and CD-1 mice exposed to a novel open space test.Michalikova S, van Rensburg R, Chazot PL, Ennaceur A.Behav Brain Res. 2010 Mar 5;207(2):402-17.ID: 19900487

Distinguishing anxiolysis and hyperactivity in an open space behavioral test.Ennaceur A, Michalikova S, van Rensburg R, Chazot PL.Behav Brain Res. 2010 Feb 11;207(1):84-98.PMID: 19800918

Detailed analysis of the behavior and memory performance of middle-aged male and female CD-1 mice in a 3D maze.Ennaceur A, Michalikova S, van Rensburg R, Chazot PL.Behav Brain Res. 2008 Mar 5;187(2):312-26 PMID: 17983672



Do rats really express neophobia towards novel objects? Experimental evidence from exposure to novelty and to an object recognition task in an open space and an enclosed space.Ennaceur A, Michalikova S, Chazot PL.Behav Brain Res. 2009 Feb 11;197(2):417-34 PMID: 18992282

Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task.Ennaceur A, Michalikova S, van Rensburg R, Chazot PL.Behav Brain Res. 2008 Mar 17;188(1):136-53. PMID: 18055029</gtr:impact><gtr:outcomeId>KSTczSXKuih-1</gtr:outcomeId><gtr:partnerContribution>Behavioural expertise to complement our pharmacological expertise in AMPA receptors</gtr:partnerContribution><gtr:piContribution>Collaboration has contributed to muliple joint publications &amp;amp; recently a joint patent file in 2010 &amp;amp; multiple publications in preparation focussing on the role of TARPS and AMPA receptors in Anxiety (using tools developed from MRC project)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>Professor Megan Holmes</gtr:description><gtr:id>98108158-1915-46CE-BFE4-833415AD0975</gtr:id><gtr:impact>Original data set which provided a functional link between AMPA and 5HT2C receptors using transgenic mice generated by Professor Holmes - currently manuscript in preparation</gtr:impact><gtr:outcomeId>BDF81C6C1C4-1</gtr:outcomeId><gtr:partnerContribution>Provided tissue from two transgenic mice (5HT2C KO and Overexpressed 5HT2C) generated by Professor Holmes</gtr:partnerContribution><gtr:piContribution>Established evidence for a functional interaction of TARPs, AMPA receptors and 5HT2C receptors in cortex and hippocampus</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Well and Dysfunction Brain Public Lectures</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>984634B0-661E-4054-8530-3FB8AF068C23</gtr:id><gtr:impact>Organised and hosted a series of Public Lectures on the Brain function and dysfunction

Attracted an audeince of 150-200 members of public</gtr:impact><gtr:outcomeId>28B2A05405D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multiple Parkinson's Disease Society Workshops</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>5A35B0AE-8E2D-4227-A5B6-0B402C579BBF</gtr:id><gtr:impact>Delivering Information workshops on Basis of Neurodegenrative diseases - including AMPA receptor related topics

Invited to become President of the North Durham PDS group</gtr:impact><gtr:outcomeId>6C1131D7D43</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Multiple School visits</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>9646DDDB-24F4-43B5-9257-0DB6F3AF82F1</gtr:id><gtr:impact>Educational talks on Brain function and Dysfuction

Excellent attendance at these and otehr Public events</gtr:impact><gtr:outcomeId>F231AAA2A28</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Festival Events</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>D59BF21E-84C3-4EB5-AF79-F252916572BB</gtr:id><gtr:impact>Host educational workshop sessions on the brain, brain function and brain dysfunction

Popular take up from school s &amp;amp; invitations to Schools</gtr:impact><gtr:outcomeId>30A16653A9F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Its a Pain Public Engagement series</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A5E6CFF1-4DAD-496E-9BEC-8D07C5664D8E</gtr:id><gtr:impact>It's Pain Public engagement series was designed by myself in collabroation with Durham &amp;amp; Darlington NHS Foundation Trust to raise awareness of the growing seriousness of chronic pain, and to develop &amp;amp; deliver a community-based approach for all ages to give advice in how to deal with long-term chronic pain, through a multidisciplinary approach including conventional up-and-coming drug and natural product, new complementary, psychological, and physiotherapy approaches. This programme is raising awareness and understanding within the General Public of chronic pain: what it is; why it can effect Quality of Life and personal relationships; the multidisciplinary way chronic pain can be managed and ultimately cured; how we might want to tackle the shortfall in pain management within the health service here in UK but also in Sub-Saharan Africa, where in some countries it is completely absent. This series involves all age groups in workshops based in schools and community centres that will be held in addition to the lectures/debates, aimed at increasing awareness of the issues around chronic pain and how to cope with it individually and how to support friends and family members. 
The first event was delivered on October 18th 2012 to an audience of nearly 200 in the Calman Building at the University of Durham, entitled &amp;quot;How The Brain Is Wired For Pain&amp;quot; - key note speaker - Dr Michael Lee, a Consultant in Pain Management from The University of Oxford. A parallel workshop took place at a school in Durham (50 year 12 &amp;amp; 13 students). The second event will take place in December 2012, focussed on the psychology of Pain (Prof Stephen Morley &amp;amp; workshop at MIND, Darlington). All events are recorded and available online gratis to the Public.

More schools have expressed interest to run workshops. Very positive feedback from 1st event and recordings. Audience of nearly 200 including Public, Health professions (Acredited by RCoA - CPD Points), academics, Undergraduates, Chief Exec Durham &amp;amp; Darlington NHS Foundation Trust.</gtr:impact><gtr:outcomeId>YEgBKHJmYSH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parkinson's UK</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7A2EC4F1-AEEF-49AF-ADE8-A23C6C2E0ABC</gtr:id><gtr:impact>North Durham Parkinoson's UK Branch

Elected president of North Durham Branch of Parkonsin's UK</gtr:impact><gtr:outcomeId>BXBm5UyV39T</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>Hungary, Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Gedeon Richter Ltd</gtr:fundingOrg><gtr:id>2A3B428A-F4AE-4101-9B2D-13D516A55E46</gtr:id><gtr:outcomeId>bEhcmDad1Cu</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2011-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Servier Studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Servier Laboratories</gtr:fundingOrg><gtr:id>A4FC21F2-55D3-4C69-9241-11266D9F01CC</gtr:id><gtr:outcomeId>992DDA025810</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>collaborative research fund/University of Sunderland</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>University of Sunderland</gtr:fundingOrg><gtr:id>1D97EB24-3F26-49B9-9B44-775D7C98168C</gtr:id><gtr:outcomeId>RR9jkXNewE60</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Mutant mouse line provided gratis to University of cardiff for ephys studies &amp;amp; continuing charcterisation</gtr:description><gtr:id>30BEEFA9-E38F-49D2-BA8F-4FCFF0340912</gtr:id><gtr:impact>Stargazer mouse line is being used as a model of temporal epilepsy

Adv Pharmacol Sci. 2011;2011:790590. Epub 2011 Sep 5.
Augmentation of Tonic GABA(A) Inhibition in Absence Epilepsy: Therapeutic Value of Inverse Agonists at Extrasynaptic GABA(A) Receptors.
Errington AC, Cope DW, Crunelli V.</gtr:impact><gtr:outcomeId>YYrqgFK56ba</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Stargazer mouse line</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Two new validated behavioural tests to assess motor activity, anxiety and learning &amp;amp; memory in a continuum in a single test setting to assess behavioural effects of modifying TARPs &amp;amp; other proteins</gtr:description><gtr:id>E14ECBAF-90E3-4A6F-B5D0-037679B7EB01</gtr:id><gtr:impact>Improved in vivo methods to assess importance of TARPs and other potential new drug targets availble to scientific community.</gtr:impact><gtr:outcomeId>mhZrFVM8vDo</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel all-in-one rodent behavioural tests of human behaviours</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Generated a new range of anti-TARP isoform selective antibodies which can be utilised in a range of immunological techniques. Provided to colleagues (work funded by British Heart Foundation project)</gtr:description><gtr:id>597D9628-A859-44DD-8ABB-95461CEBCF8A</gtr:id><gtr:impact>Generated new information relating to identification of novel TARP gamma 2 and 8 binding partners from cortex and cerebellum Form the basis for probing AMPA receptor regulation in terms of chronobiology and anxiety behaviours in rodents Tools for investigating the mechanism of action of third-generation anti-depressant drugs in progress (2 x PhD projects - one complete and one nearing completion) in collaboration with Unversity of Edinburgh and Servier (France)</gtr:impact><gtr:outcomeId>3DAD464F601</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Range of new Immunological tools</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Using the stg mouse, a new primary culture model has been developed which selectively removes AMPA function &amp;amp; maintaining kainate function in cerebellar granule cell cultures</gtr:description><gtr:id>077AB5C9-E5F0-4B7D-BA17-E5429DFAE3A0</gtr:id><gtr:impact>Publication &amp;amp; manuscripts in preparation</gtr:impact><gtr:outcomeId>2004EB68DB6</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel cell culture model to dissect kainate from AMPA receptor function</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>86CAF133-4857-4072-8CC2-8680CF92898B</gtr:id><gtr:title>MK-801 increases the baseline level of anxiety in mice introduced to a spatial memory task without prior habituation.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c65b1c8ce9fb8cec39d4f4bf5e39e0c0"><gtr:id>c65b1c8ce9fb8cec39d4f4bf5e39e0c0</gtr:id><gtr:otherNames>Ennaceur A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>pm_15093_23_21762710</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8ECAE84D-A683-44B9-B783-AC0EA67B9891</gtr:id><gtr:title>AMPA and kainate receptors mediate mutually exclusive effects on GABA(A) receptor expression in cultured mouse cerebellar granule neurones.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/825b994e194b9c579976fb913455db49"><gtr:id>825b994e194b9c579976fb913455db49</gtr:id><gtr:otherNames>Payne HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>42D384B8E05</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>000B8B2D-FC62-487A-84F4-6C59240D6B80</gtr:id><gtr:title>Detailed analysis of the behavior and memory performance of middle-aged male and female CD-1 mice in a 3D maze.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c65b1c8ce9fb8cec39d4f4bf5e39e0c0"><gtr:id>c65b1c8ce9fb8cec39d4f4bf5e39e0c0</gtr:id><gtr:otherNames>Ennaceur A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>pm_15093_13_17983672</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49C3BD93-75BC-4DE4-A346-44B7F9EA8726</gtr:id><gtr:title>Aberrant cerebellar granule cell-specific GABAA receptor expression in the epileptic and ataxic mouse mutant, Tottering.</gtr:title><gtr:parentPublicationTitle>Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590d2daa74496f6059d66b813330b04d"><gtr:id>590d2daa74496f6059d66b813330b04d</gtr:id><gtr:otherNames>Kaja S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0306-4522</gtr:issn><gtr:outcomeId>D6C73E7F89C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B07D402E-D807-4CF0-8F55-0EF53F741DF5</gtr:id><gtr:title>Slope climbing challenges, fear of heights, anxiety and time of the day.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c65b1c8ce9fb8cec39d4f4bf5e39e0c0"><gtr:id>c65b1c8ce9fb8cec39d4f4bf5e39e0c0</gtr:id><gtr:otherNames>Ennaceur A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>58c2c311ebe772.16485067</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF972F47-49D7-49FA-94FF-D81F5BF3823F</gtr:id><gtr:title>Aberrant GABA(A) receptor expression in the dentate gyrus of the epileptic mutant mouse stargazer.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/825b994e194b9c579976fb913455db49"><gtr:id>825b994e194b9c579976fb913455db49</gtr:id><gtr:otherNames>Payne HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>A386D807EF1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B094146-6018-4856-905D-37ECE053417B</gtr:id><gtr:title>GABAA alpha6-containing receptors are selectively compromised in cerebellar granule cells of the ataxic mouse, stargazer.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/825b994e194b9c579976fb913455db49"><gtr:id>825b994e194b9c579976fb913455db49</gtr:id><gtr:otherNames>Payne HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>AC7EEB65137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5713848A-D991-4B14-89C3-97AC19F172C6</gtr:id><gtr:title>Activity- and development-dependent down-regulation of TARP?8 and GluA1 in cultured rat hippocampal neurons.</gtr:title><gtr:parentPublicationTitle>Acta pharmacologica Sinica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3353f6d52aa72ee2c9465a9c88fff064"><gtr:id>3353f6d52aa72ee2c9465a9c88fff064</gtr:id><gtr:otherNames>Wang JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1671-4083</gtr:issn><gtr:outcomeId>56d45219441291.93335168</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23D6B74D-70EB-40CB-BFF1-9E7251375EE2</gtr:id><gtr:title>Emotional responses and memory performance of middle-aged CD1 mice in a 3D maze: effects of low infrared light.</gtr:title><gtr:parentPublicationTitle>Neurobiology of learning and memory</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fd54ebf643709a166e87fc0094a72dce"><gtr:id>fd54ebf643709a166e87fc0094a72dce</gtr:id><gtr:otherNames>Michalikova S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1074-7427</gtr:issn><gtr:outcomeId>pm_15093_13_17855128</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E864D807-7D32-4AA6-BEB4-EA01C84D1B93</gtr:id><gtr:title>Effects of NMDA receptor antagonists with different subtype selectivities on retinal spreading depression.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737ffe0e530a693d7c0da01892f1528d"><gtr:id>737ffe0e530a693d7c0da01892f1528d</gtr:id><gtr:otherNames>Wang M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn><gtr:outcomeId>pm_15093_23_21699507</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E300C007-2CE0-4C3C-B822-11B354A14A69</gtr:id><gtr:title>The role of transmembrane AMPA receptor regulatory proteins (TARPs) in neurotransmission and receptor trafficking (Review).</gtr:title><gtr:parentPublicationTitle>Molecular membrane biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/825b994e194b9c579976fb913455db49"><gtr:id>825b994e194b9c579976fb913455db49</gtr:id><gtr:otherNames>Payne HL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0968-7688</gtr:issn><gtr:outcomeId>905EAEEED5B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C67450E1-83E9-489C-8749-2EC8A803257D</gtr:id><gtr:title>Preclinical animal anxiety research - flaws and prejudices.</gtr:title><gtr:parentPublicationTitle>Pharmacology research &amp; perspectives</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c65b1c8ce9fb8cec39d4f4bf5e39e0c0"><gtr:id>c65b1c8ce9fb8cec39d4f4bf5e39e0c0</gtr:id><gtr:otherNames>Ennaceur A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2052-1707</gtr:issn><gtr:outcomeId>58c2c49c262139.07654920</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401395</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>